Device Empower Leadless Pacemaker System_crm

Empower Leadless Pacemaker System_crm

Payments companies reported to CMS as associated with Empower Leadless Pacemaker System_crm. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3,268associated payments (2023-2025)
65clinicians with associated payments
1company reporting

By year

2025 $3,268

Payments reported as associated with Empower Leadless Pacemaker System_crm, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $1,247
Cardiovascular Disease $983
Internal Medicine $221
Nurse Practitioner $192
Physician Assistant $188
Family $129

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Empower Leadless Pacemaker System_crm

These are the largest totals companies reported as associated with Empower Leadless Pacemaker System_crm. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Saarik Gupta Santa Monica, CA Cardiovascular Disease $158.26
Jeffrey Gordon Allentown, PA Clinical Cardiac Electrophysiology $143.13
Hamid Sattar Dearborn, MI Cardiovascular Disease $117.26
Markus Meyer Minneapolis, MN Cardiovascular Disease $107.32
David Benditt St Cloud, MN Cardiovascular Disease $107.32
Lisa Von Wald Minneapolis, MN Nurse Practitioner $107.32
Venkatakrishna Tholakanahalli Minneapolis, MN Clinical Cardiac Electrophysiology $107.31
Shannon Mcknight Arden Hills, MN Physician Assistant $107.31
Henri Roukoz Minneapolis, MN Clinical Cardiac Electrophysiology $107.31
Rehan Karim Minneapolis, MN Clinical Cardiac Electrophysiology $107.31

Prescribed Empower Leadless Pacemaker System_crm?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.